Volastra Therapeutics’ Extended $44M Seed Financing

Wilmer Cutler Pickering Hale and Dorr LLP advised Volastra Therapeutics on the deal.Volastra Therapeutics, a biotechnology company developing novel therapies for the prevention and treatment of…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here